Struggling to find Lantus at your pharmacy? Learn why Lantus and Insulin Glargine are hard to find in 2026, what's causing the shortage, and what you can do.
You showed up at the pharmacy with your prescription, only to hear the words no one with diabetes wants to hear: "We don't have Lantus in stock right now." If this has happened to you lately, you're far from the only one. Across the country, patients who depend on Lantus (Insulin Glargine) for daily blood sugar management are running into empty shelves and long wait times.
Let's break down what's going on, why Lantus is hard to find, and — most importantly — what you can do about it.
Lantus is a brand-name long-acting insulin made by Sanofi. Its active ingredient is Insulin Glargine, a synthetic version of human insulin that works for up to 24 hours after injection. It's prescribed to adults and children (6 years and older) with type 1 diabetes and adults with type 2 diabetes to provide a steady "basal" level of insulin throughout the day.
Lantus comes in two forms: a 10 mL vial and a prefilled SoloStar pen. Patients typically inject it once daily at the same time each day, and it's one of the most commonly prescribed insulins in the United States.
There isn't one single reason Lantus is hard to find — it's a combination of factors hitting the insulin market all at once.
One of the biggest disruptions came at the end of 2025, when Biocon discontinued Semglee (Insulin Glargine-yfgn), a popular biosimilar that was interchangeable with Lantus. Semglee had been a go-to lower-cost option for many patients and insurance plans. When it disappeared, demand shifted heavily toward brand Lantus and other Insulin Glargine products, straining supply chains.
Many insurance plans had Semglee as their preferred Insulin Glargine product. When Semglee became unavailable, insurers scrambled to update their formularies. Some plans now cover Lantus where they didn't before, but the transition has been messy — leaving patients stuck between old authorizations and new coverage rules.
Even when Sanofi has Lantus available at the manufacturing level, getting it to every pharmacy across the country involves a complex distribution network. Regional shortages can pop up when wholesalers and distributors can't keep up with sudden demand spikes, especially in areas where Semglee was heavily prescribed.
Diabetes rates continue to rise in the United States. The CDC estimates over 38 million Americans have diabetes, and that number keeps growing. More patients needing insulin means more pressure on every product in the category, including Lantus.
Running low on insulin is stressful — and potentially dangerous. Here are steps you can take right now:
Instead of calling pharmacy after pharmacy, use Medfinder to search for pharmacies near you that have Lantus in stock. It saves time and helps you find what you need faster.
Big chain pharmacies often face the highest demand. Independent and community pharmacies sometimes have stock when the chains don't. They may also be more willing to help you track down your medication.
If Lantus is truly unavailable in your area, your prescriber may be able to switch you to another Insulin Glargine product like Basaglar or Toujeo, or a different long-acting insulin like Tresiba (Insulin Degludec). Read more in our guide to alternatives to Lantus.
Sanofi's patient support team can sometimes help locate pharmacies with available stock or connect you with their Valyou Savings Program, which caps your cost at $35 per month.
This is the most important advice: never skip your insulin without talking to your doctor first. Missing basal insulin can lead to dangerously high blood sugar, diabetic ketoacidosis (DKA), and other serious complications.
The outlook is cautiously optimistic. Sanofi has confirmed that Lantus remains in production, and other manufacturers continue to supply generic Insulin Glargine. As insurance plans finish updating their formularies and distribution networks adjust, availability should stabilize through 2026.
In the meantime, staying proactive is your best strategy. Check stock regularly using Medfinder, stay in touch with your prescriber, and explore savings options to keep your costs manageable. For more on pricing, check out our guide on how to save money on Lantus in 2026.
Finding Lantus shouldn't be this hard — but right now, it is for many people. The good news is that there are real steps you can take, from using stock-checking tools to talking with your doctor about alternatives. You don't have to figure this out alone.
If you're struggling to find Lantus or any other medication, Medfinder can help you search pharmacies near you and find what you need, faster.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
